
84 tickers with net accumulation ≥ 2 days (accumulation day = +2% on >1.5x 20-day avg volume; market cap ≥ $1B). Ranked by institutional dollars.
| # | Symbol | Sector | MC | Acc d | Dist d | Acc $ | 20d ret |
|---|---|---|---|---|---|---|---|
| 1 | PLTR | Technology | $446.9B | 3 | 0 | $22.9B | +1.6% |
| 2 | ACN | Technology | $153.3B | 2 | 0 | $8.7B | +23.4% |
| 3 | IONQ | Technology | $12.7B | 3 | 0 | $6.7B | -22.8% |
| 4 | SNPS | Technology | $87.1B | 2 | 0 | $5.2B | +13.1% |
| 5 | IBM | Technology | $218.7B | 2 | 0 | $4.0B | +0.1% |
| 6 | VRTX | Healthcare | $126.7B | 2 | 0 | $2.2B | -2.1% |
| 7 | STZ | Consumer Defensive | $22.2B | 3 | 0 | $2.1B | +10.9% |
| 8 | CCI | Real Estate | $35.0B | 2 | 0 | $1.9B | +12.3% |
| 9 | IOVA | Healthcare | $6.2B | 2 | 0 | $1.6B | +33.7% |
| 10 | DKS | Consumer Cyclical | $12.8B | 2 | 0 | $1.4B | +16.8% |
| 11 | CBOE | Financial Services | $32.9B | 2 | 0 | $1.3B | +16.0% |
| 12 | BTI | Consumer Defensive | $129.6B | 2 | 0 | $1.3B | +7.6% |
| 13 | HIMS | Healthcare | $6.5B | 2 | 0 | $1.0B | -4.4% |
| 14 | CPNG | Consumer Cyclical | $25.7B | 2 | 0 | $0.9B | -2.4% |
| 15 | INFY | Technology | $49.7B | 2 | 0 | $0.8B | +12.4% |
| 16 | INOD | Technology | $1.8B | 2 | 0 | $0.7B | -13.5% |
| 17 | Z | Communication Services | $6.9B | 2 | 0 | $0.7B | +0.6% |
| 18 | SMMT | Healthcare | $11.7B | 2 | 0 | $0.7B | -13.4% |
| 19 | TRU | Financial Services | $14.2B | 2 | 0 | $0.7B | +3.7% |
| 20 | ERIC | Technology | $35.6B | 2 | 0 | $0.6B | +2.9% |
| 21 | DOCS | Healthcare | $5.5B | 3 | 0 | $0.4B | +15.4% |
| 22 | ESLT | Industrials | $35.1B | 3 | 0 | $0.4B | +0.6% |
| 23 | VSTM | Healthcare | $1.1B | 2 | 0 | $0.4B | +8.3% |
| 24 | SBS | Utilities | $22.0B | 3 | 0 | $0.4B | +15.1% |
| 25 | CX | Basic Materials | $15.5B | 3 | 0 | $0.4B | +2.3% |
_Footprints, not proof: high-volume up-days show institutional-size buying but not who is buying._
Market-structure reporting: capital flows, breadth and volume signals across Fam's watchlist. Not personalized investment advice, and not buy or sell recommendations.